607 related articles for article (PubMed ID: 33912193)
1. Paroxysmal Sympathetic Hyperactivity in Severe Anti-N-Methyl-d-Aspartate Receptor Encephalitis: A Single Center Retrospective Observational Study.
Wang D; Su S; Tan M; Wu Y; Wang S
Front Immunol; 2021; 12():665183. PubMed ID: 33912193
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and Outcomes of Paroxysmal Sympathetic Hyperactivity in Anti-NMDAR Encephalitis.
Chen Z; Zhang Y; Wu X; Huang H; Chen W; Su Y
Front Immunol; 2022; 13():858450. PubMed ID: 35464412
[TBL] [Abstract][Full Text] [Related]
3. Incidence of paroxysmal sympathetic hyperactivity following traumatic brain injury using assessment tools.
Samuel S; Lee M; Brown RJ; Choi HA; Baguley IJ
Brain Inj; 2018; 32(9):1115-1121. PubMed ID: 29856656
[TBL] [Abstract][Full Text] [Related]
4. Paroxysmal sympathetic hyperactivity in severe traumatic brain injury.
Mathew MJ; Deepika A; Shukla D; Devi BI; Ramesh VJ
Acta Neurochir (Wien); 2016 Nov; 158(11):2047-2052. PubMed ID: 27581717
[TBL] [Abstract][Full Text] [Related]
5. Paroxysmal sympathetic hyperactivity in the neurological intensive care unit.
Rabinstein AA
Neurol Res; 2007 Oct; 29(7):680-2. PubMed ID: 18173907
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and prognostic study of anti-N-methyl-D-aspartate receptor encephalitis children with paroxysmal sympathetic hyperactivity syndrome].
Feng S; Chen JX; Liu S; Zheng P; Sun J; Zhang X; Chen Q
Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(43):3600-3603. PubMed ID: 34808755
[TBL] [Abstract][Full Text] [Related]
7. Paroxysmal Sympathetic Hyperactivity in Critically Ill Children with Encephalitis and Meningoencephalitis.
Farias-Moeller R; Carpenter JL; Dean N; Wells EM
Neurocrit Care; 2015 Dec; 23(3):380-5. PubMed ID: 25724178
[TBL] [Abstract][Full Text] [Related]
8. The use of the PSH-AM in patients with diffuse axonal injury and autonomic dysregulation: A cohort study and review.
van Eijck MM; Sprengers MOP; Oldenbeuving AW; de Vries J; Schoonman GG; Roks G
J Crit Care; 2019 Feb; 49():110-117. PubMed ID: 30415180
[TBL] [Abstract][Full Text] [Related]
9. Paroxysmal sympathetic hyperactivity in pediatric traumatic brain injury: A case series of four patients.
Deepika A; Mathew MJ; Kumar SA; Devi BI; Shukla D
Auton Neurosci; 2015 Dec; 193():149-51. PubMed ID: 26277041
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients.
Jiang XY; Lei S; Zhang L; Liu X; Lin MT; Blumcke I; Piao YS; Zhou D; Li JM
Acta Neuropathol Commun; 2020 Aug; 8(1):130. PubMed ID: 32771066
[TBL] [Abstract][Full Text] [Related]
11. Influence of paroxysmal sympathetic hyperactivity (PSH) on the functional outcome of neurological early rehabilitation patients: a case control study.
Totikov A; Boltzmann M; Schmidt SB; Rollnik JD
BMC Neurol; 2019 Jul; 19(1):162. PubMed ID: 31315589
[TBL] [Abstract][Full Text] [Related]
12. Paroxysmal sympathetic hyperactivity after traumatic brain injury: clinical and prognostic implications.
Fernandez-Ortega JF; Prieto-Palomino MA; Garcia-Caballero M; Galeas-Lopez JL; Quesada-Garcia G; Baguley IJ
J Neurotrauma; 2012 May; 29(7):1364-70. PubMed ID: 22150061
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognosis of paroxysmal sympathetic hyperactivity in patients with severe nontraumatic brain injury.
Miao H; Huang H; Chen W; Su YY; Zhang Y
Brain Inj; 2023 Jan; 37(2):95-100. PubMed ID: 36662125
[TBL] [Abstract][Full Text] [Related]
14. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor Encephalitis.
Morgan A; Li Y; Thompson NR; Milinovich A; Abbatemarco JR; Cohen JA; Ontaneda D; Punia V; Rae-Grant A; Galioto R; Kunchok A
Neurology; 2024 Feb; 102(4):e208019. PubMed ID: 38266213
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Treatment of Paroxysmal Sympathetic Hyperactivity in Medical ICU, University of Gondar Hospital, Northwest Ethiopia: A Case Report.
Bekele N; Mesfin N; Hailu T; Tadesse A
Int Med Case Rep J; 2020; 13():591-595. PubMed ID: 33204177
[TBL] [Abstract][Full Text] [Related]
17. Overlapping Physiologic Signs of Sepsis and Paroxysmal Sympathetic Hyperactivity After Traumatic Brain Injury: Exploring A Clinical Conundrum.
Salasky VR; Chowdhury SH; Chen LK; Almeida E; Kong X; Armahizer M; Pajoumand M; Schrank GM; Rabinowitz RP; Schwartzbauer G; Hu P; Badjatia N; Podell JE
Neurocrit Care; 2024 Jun; 40(3):1006-1012. PubMed ID: 37884690
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of clinical characteristics and outcomes of mechanically ventilated patients with anti-N-methyl-D-aspartate receptor encephalitis].
Zhang Y; Su YY; Gao DQ; Ye H
Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):187-192. PubMed ID: 28162168
[No Abstract] [Full Text] [Related]
19. Weathering the storm: a single-institution experience with paroxysmal sympathetic hyperactivity after brain tumor resection in pediatric patients.
Bouchal SM; Naylor RM; Daniels DJ
J Neurosurg Pediatr; 2023 Apr; 31(4):282-289. PubMed ID: 36609373
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and Management of Patients with Paroxysmal Sympathetic Hyperactivity following Acute Brain Injuries Using a Consensus-Based Diagnostic Tool: A Single Institutional Case Series.
Godo S; Irino S; Nakagawa A; Kawazoe Y; Fujita M; Kudo D; Nomura R; Shimokawa H; Kushimoto S
Tohoku J Exp Med; 2017 Sep; 243(1):11-18. PubMed ID: 28890524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
